Fourth, ARID1A‐depleted cancer cells are more sensitive to the enhancer of zeste homolog 2 methyltransferase (EZH2) inhibitors because ARID1A and EZH2 are functionally antagonistic in the control of gene expression.28 This evidence concerns the gene ARID1A and cancer.